Position in FTRE
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$14,036,162
+$9,805,820 QoQ
Shares Held
806,676
+79.6% QoQ
Ownership
0.848%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#29
of 334 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FTRE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRINCIPAL FINANCIAL GROUP INC holds $1,857,842,341 across 105 Biotechnology names. FTRE ranks #31 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
873,502 | $232,980,453 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
389,511 | $193,481,798 | |
| 3 | CYTK |
Cytokinetics Inc
|
1,311,664 | $111,740,655 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
1,752,753 | $94,070,253 | |
| 5 | INSM |
INSMED Inc
|
856,126 | $91,280,154 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
332,642 | $81,420,782 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
1,024,423 | $76,299,024 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
121,053 | $75,481,386 |
All Filings in FTRE
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,036,162 | 806,676 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $4,230,342 | 449,081 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $8,335,596 | 483,223 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $4,358,023 | 517,580 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $2,217,007 | 448,787 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $3,368,809 | 446,200 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $8,111,873 | 434,953 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $8,438,540 | 421,927 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $10,249,736 | 439,149 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $19,374,774 | 482,680 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $15,956,663 | 457,211 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $13,470,235 | 471,152 | Shares | Defined | 2023-11-02 | |
| No filing history on record for this holder in this stock. | ||||||